CAIRE expands into cardiorespiratory market

BALL GROUND, Ga. – CAIRE, a subsidiary of NGK Spark Plug, has announced its plans to acquire St. Paul, Minn.-based MGC Diagnostics Holdings.

MGC designs, develops, manufactures and markets non-invasive cardiorespiratory diagnostic systems, accessories and consumables for the detection, classification and management of cardiorespiratory disease.

“CAIRE is firmly committed to driving future growth by expanding our offerings in the clinical setting to better serve those individuals affected by cardiorespiratory diseases,” said Earl Lawson, CAIRE president and CEO. “MGC has a state-of-the-art portfolio that is widely adopted to diagnose respiratory disease and to ensure that the information obtained benefits disease management. These tools are an excellent complement to CAIRE’s complete range of oxygen therapy solutions. Furthermore, we are very excited to work with the talented MGC senior management team and global team of professionals who were responsible for the strategic planning and execution driving MGC’s strong growth. This will be key to a seamless integration of the business and the ongoing expansion in the marketplace.”

The deal is expected to close by the end of the year.

MGC, the No. 2 player globally in the cardiorespiratory diagnostics market, has facilities in Belgium, Germany, France and Australia, in addition to St. Paul, and employs 200. Its product portfolio includes pulmonary function testing systems, cardiopulmonary exercise systems, spirometers, flow sensors, gas analyzers, and associated consumables.

“The MGC team is excited to become a part of the CAIRE organization,” said Todd Austin, MGC CEO. “After outperforming the market consistently, we look forward to leveraging the resources of CAIRE and NGK Spark Plug to drive continued growth in our existing markets and to launch new products and technologies through our best-in-class distribution channels.”